Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

76.83 USD -0.24 (-0.31%)
Streaming Delayed Price Updated: 7:18 AM EST, Jan 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Here's Why Amazon Will Never Be a Dow Jones Industrials Stock
One of the world's most important businesses is being ignored by one of the most important indexes. 
Tags MRK CSCO BA
From Motley Fool
Noteworthy ETF Inflows: XLV, JNJ, MRK, PFE
Symbols mentioned in this story: XLV, JNJ, MRK, PFE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity and Reducing Preventable Maternal Deaths in the US
Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity in the US 
From Business Wire News Releases
The January Effect
There have been a small number of consistent alpha-creating axioms in the U.S. stock market over time. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Merck Announces Second-Quarter 2021 Dividend
Merck Announces Second-Quarter 2021 Dividend 
From Business Wire News Releases
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P 2021
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P 
From Business Wire News Releases
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags News AUPH VAR
From Benzinga
Merck Just Scrapped Its Coronavirus Vaccines — Is Merck Stock A Buy?
Merck stock dipped in late January after the Dow Jones pharmaceutical company scrapped development of two "inferior" coronavirus vaccines. Is Merck stock a buy? 
From Investor's Business Daily
European Commission Approves KEYTRUDA® (pembrolizumab) as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal
European Commission Approves KEYTRUDA as First-Line Treatment in Adult Patients With Metastatic MSI-H or dMMR Colorectal Cancer 
From Business Wire News Releases
Warren Buffett's 3 Biggest Stock Picks for 2021
Here's what the Oracle of Omaha is betting on for the coming year. 
Tags AAPL BAC GS
From Motley Fool
Trade War Coming
There is a trade war coming between Germany and the USA because of rivalry on stimulus for the COVID epidemic. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Merck Gives Up on Coronavirus Vaccines
The company will focus on antiviral and anti-inflammatory treatments for patients infected with COVID-19. 
Tags Market News MRK
From Motley Fool
Dow Pares Big Loss, Nasdaq Hits New High As Apple Stock Rallies Ahead Of Earnings
Key indexes closed mixed Monday, as the Nasdaq hit a fresh closing high and the Dow Jones Industrial Average trimmed most of a 432-point loss. 
From Investor's Business Daily
Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 headed closer to 100 million on Monday with the U.S. accounting for a quarter of that total, as President Joe Biden... 
Tags MRK Health/Care UK:AZN
From MarketWatch
Merck Scraps Development Of 'Inferior' Covid Vaccines; Shares Dip
Merck stock dipped Monday after the company scrapped development of two coronavirus vaccines that the company said proved inferior to already authorized drugs by other pharma players. 
From Investor's Business Daily
ROCE Insights For Merck & Co
Merck & Co (NYSE:MRK) posted a 0.42% decrease in earnings from Q2. Sales, however, increased by 15.44% over the previous quarter to ... 
Tags Market News News BZI/ROCE
From Benzinga
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN. 
From PR Newswire
Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates
Merck announced that the company is discontinuing the development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591. 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings
SciPlay and Regeneron were early leaders, Apple led the Dow Jones today as stock futures geared for the heaviest week of the Q4 reporting season. 
From Investor's Business Daily
Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results
Merck & Co., Inc. (NYSE: MRK), which was a late entrantto the COVID-19 vaccine fray, has dropped out of the race, and has ... 
Tags MRNA Benzinga PFE
From Benzinga
Implied FTXH Analyst Target Price: $30
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stock futures rise ahead of big week for tech earnings
Stock-index futures trade higher Monday, finding support ahead of a busy week of earnings that features results from Apple Inc., Tesla Inc. and Facebook Inc. 
Tags ES00 NQ00 SPX
From MarketWatch
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates 
From Business Wire News Releases
Embrace the ProShares Pet Care ETF as People Add Pets to the Family
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>More people have pets -- and are spending more on their pets. The PAWZ... 
Tags MRK ETF Investing CVET
From InvestorPlace
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market ... 
Tags JNJ RYTM ABMD
From Benzinga
Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg
The biotech has a promising -- and expanding -- pipeline. 
Tags MRNA MRK AZN
From Motley Fool
Bristol Myers Stock Is Eyeing A Buy Point At A 5-Year High — Is It A Buy?
Bristol Myers Squibb is poised for double-digit growth in 2020, thanks to its acquisition of Celgene. And, BMY stock is now trading near a five-year high. So, is BMY stock a buy? 
From Investor's Business Daily
The 7 Best Healthcare Stocks to Buy for 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Politics is a wildcard that can negatively impact healthcare stocks. But... 
Tags XLV MRK JNJ
From InvestorPlace
Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
From PR Newswire
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BDSX CALT DTIL
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.